IDT Australia purchases 23 generics from Global Generics Company

300px-Flag_of_Australia.svg

IDT Australia Limited has announced the acquisition of 23 generic drugs from the Global Generics Company. The purchase was made for a total of $14.8 million dollars. Among the drugs purchased are treatments for depression, Parkinson’s, hypertension, and pain management, among others. IDT is looking to immediately begin manufacturing the newly acquired drugs at the company’s Melbourne manufacturing facility. IDT had wanted to strengthen its generics portfolio.

 

Read the source article at Pharmacy Choice

About the Author

Related Posts

Leave a Reply

*